Loading...
Modern Chinese Medicine Group Co., Ltd.
1643.HK•HKSE
HealthcareDrug Manufacturers - General
$0.35
$0.02(5.97%)
Modern Chinese Medicine Group Co., Ltd. (1643.HK) Stock Overview
Explore Modern Chinese Medicine Group Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for 1643.HKStats details for 1643.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for 1643.HKAnalyst Recommendations details for 1643.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China. It offers therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, respiratory system, and nervous system conditions. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. is a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.
CEO
Ms. Hongli Zhang
Employees
190
Headquarters
No. 88, Jinwei Road, Chengde
Founded
2021